Cipla began in 1935 when their founder Dr KA Hamid set up an enterprise with the vision to make India self-sufficient in healthcare.
Presently, they have 34 state-of-the-art manufacturing facilities that make Active Pharmaceutical Ingredients (APIs) and formulations, which have been approved by major international Regulatory Agencies, along with over 2000 products in 65 therapeutic categories. The company manufactures 40 dosage forms, covering a wide spectrum of diseases ranging from communicable, non-communicable, common and emerging diseases to even rare diseases.
Today, they are one of the world’s largest generic pharmaceutical companies with a strong presence in over 170 countries, with an assurance to maintain world-class quality across all their products and services.
CIPLA: PROVIDING HEALTHCARE TO THE COUNTRY
|2011||Receives ‘Outstanding Export Performance’ award in the export of pharmaceuticals and is conferred the highest award – ‘Platinum’|
|2007||Gets listed in Forbes Asia’s ‘Best under A Billon’|
|2006||Receives International Trade Award for Outstanding Exporter of The Year (pharmaceuticals, healthcare and life sciences category)|
|2006||Receives Silver Plate Award by Helpage India in 2006|
|2005||Receives Pharma Excellence Award for 'Sustained Growth'|